Endocrine oncology

Frequency and impact of musculoskeletal symptoms on quality of life in MEN2B

Clin Endocrinol (Oxf)Published Cross-sectional study

Authors' conclusion

We report a high prevalence of musculoskeletal-related complaints in MEN2B which significantly affects QOL. This suggests a need to provide better holistic care including a multidisciplinary team with physiotherapist, orthopaedic and dental specialist input.

Study context

Population
Patients with MEN2B (Association for Multiple Endocrine Neoplasia Disorders (AMEND) members and worldwide social media group)completed survey
Participants
48 patients
Outcome
MSK-related symptoms and impact on QOL
Methodological detailsonline survey, distributed by AMEND and via social media group
  • Online survey
  • Distributed by AMEND and via social media group

Main finding

As reported in the abstract

Musculoskeletal (MSK) weakness
73% (n = 35)
Pain
58% (n = 28)
Median pain score (IQR)
7 (5-8)
Pain daily
44% (n = 15)
Pain constant
21% (n = 7)
Physique 'different'
63% (n = 30)
Marfanoid body features
40% (n = 19)
Scoliosis
70% (n = 16)
Pes cavus
63% (n = 22)
Dental problems
69% (n = 33)
Interdental spacing
61% (n = 20)
Median impact of MSK symptoms on quality of life (QOL) (IQR)
6 (3-9)
Highest impact: structural deformities
53% (n = 18)
Highest impact: pain
26% (n = 9)

Observational data: associations, not effects.

Original publication

Frequency and impact of musculoskeletal symptoms on quality of life in MEN2B. Clin Endocrinol (Oxf). Published 4 October 2022. doi:10.1111/cen.14823

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.